Home » Topics » Conferences

Conferences
RSS

Searle characterizes new vitronectin antagonist with antitumor activity at ACS meeting

March 25, 1999

R.W. Johnson identifies mixed adrenergic agent with analgesic activity

March 25, 1999

NIP-142: a new-concept antiarrhythmic agent is presented by Nissan Chemical

March 25, 1999

Hokuriku Seiyaku discusses new agents for constipation at Japanese meeting

March 25, 1999

CCK-A antagonist from Zeria shows promising activity in pancreatitis models

March 25, 1999

Gastrointestinal effects and binding profile of Taisho's 5-HT4 agonist TS-951

March 25, 1999

Dainippon's AH-9700 is an excellent candidate for treatment of urge incontinence

March 25, 1999

ACS presentation for LY-377604, Lilly's beta3-agonist for metabolic syndrome

March 24, 1999

Highlights from ACS: potent and selective alpha2-blocker presented by Pierre Fabre

March 24, 1999

New series of benzimidazole ribosides for HCMV infection discovered at Glaxo Wellcome

March 24, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...